Goflikicept (RPH 104) 是一种杂合蛋白，可选择性结合并灭活循环中的 IL-1ss 和 IL-1α。Goflikicept 具有研究 ST 段抬高心肌梗死 (STEMI) 的潜力。
| 生物活性 | Goflikicept (RPH 104) is a hybrid protein that selectively binds and inactivates both circulating IL-1ss and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI)[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
